HCA Healthcare Inc. (NYSE:HCA) does about 1.35M shares in volume on a normal day but saw 1888061 shares change hands in Monday trading. The company now has a market cap of 73.32B USD. Its current market price is $263.81, marking an increase of 0.92% compared to the previous close of $261.40. The 52 week high reached by this stock is $279.02 whilst the lowest price level in 52 weeks is $164.47. The script in recent trading has seen the stock touch a high of $269.09 and a low of $262.11.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
HCA Healthcare Inc. (HCA) has a 20-day trading average at $249.97 and the current price is -5.45% off the 52-week high compared with 60.40% distance from its 52-week low. The 50-day simple moving average of the closing price is $240.83 and its 200-day simple moving average is $215.00. If we look at the stock’s price movements over the week, volatility stands at 2.50%, which decreases to 2.08% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 72.88 to suggest the stock is overbought.
The consensus objective for the share price is $265.55, suggesting that the stock has a potential upside of 0.66% over the period. The median price target is 0.82% away from the current levels at $266.00.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 06, 2022 when BMO Capital Markets downgraded the stock to “Underperform” and issued a price target of between $233 and $160. Bernstein upgraded its price target at $273-$271.
The current price level is 5.98%, 10.02%, and 22.76% away from its SMA20, SMA50, and SMA200 respectively, with the HCA price moving above the 50-day SMA on January 23. HCA Healthcare Inc. (HCA) stock is up 1.91% over the week and 10.68% over the past month. Its price is 9.94% year-to-date and 9.57% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/29/2022, with the company’s earnings per share (EPS) of $3.93 above consensus estimates by $0.05. HCA’s earnings per share are forecast to shrink by -2.30% this year and 7.10% over next year. Expected sales for next quarter are $15.44 billion, which analysts say will come at $60.43 billion for the current fiscal year and next year at $62.91 billion. In addition, estimates put the company’s current quarterly revenue at an average of $15.59 billion.
Its 12-month price target is $266.00. To reach the target analysts have set, the stock logically needs to grow 0.66 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $150.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $308.00.
Outstanding shares total 285.96M with insiders holding 25.07% of the shares and institutional holders owning 67.25% of the company’s common stock. The company has a return on investment of 22.50% and return on equity of -214.70%. The price to earnings ratio (P/E ratio) amounts to 14.90 while the forward price to earnings ratio is 14.48. The beta has a value of 1.65. Price to sales ratio is 1.23.
According to a U.S. Securities and Exchange Commission filing, Vanguard Wellington Fund has added its position in HCA Healthcare Inc. (HCA) to 6,560,183 shares, mirroring a recent increase by 6.06%. Vanguard Wellington Fund added 0.37 million shares of HCA Healthcare Inc. common stock bringing its total worth to about $1.57 billion at the end of recent close, SEC documents show. Vanguard Wellington Fund isn’t the only investment manager who changed stakes and is followed by Vanguard Total Stock Market Index, which sold off 38617.0 shares to end up with 6,449,762 shares worth $1.55 billion. Vanguard 500 Index Fund cut their holdings by -0.63% in the company over the course of the most recent quarter. It now holds a 1.73% position in HCA Healthcare Inc. thanks to 4.9 million shares amounting to $1.18 billion.
